Market Place
Sourcing Support
Innovation Provides Update on U.S. Patent Applications Use of Brilacidin
21 Jun 2023 //
GLOBENEWSWIRE
Innovation Announces BeaMed Breakthrough in Development of Fiber Optic Probes
05 Jun 2023 //
GLOBENEWSWIRE
Innovation Pharmaceuticals Brilacidin Antifungal Research Published
17 Apr 2023 //
GLOBENEWSWIRE
Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin
15 Mar 2023 //
GLOBENEWSWIRE
Innovation Pharmaceuticals Visits BeaMed
23 Feb 2023 //
GLOBENEWSWIRE
Innovation Pharma Announces BT BeaMedical and Shina Enter into Agreement
09 Jan 2023 //
GLOBENEWSWIRE
Innovation Pharma Reports Vivo Antifungal Data Showing Brilacidin’s Potential
13 Dec 2022 //
GLOBENEWSWIRE
Innovation Announces BT BeaMedical Receives FDA Clearance for Surgical Family
28 Nov 2022 //
GLOBENEWSWIRE
Innovation Pharmaceuticals Announces Publication of Scientific Article
04 Oct 2022 //
GLOBENEWSWIRE
Innovation Pharmaceuticals` Investment in BT BeaMedical
13 Sep 2022 //
ACCESSWIRE
Innovation`s NIH/NIAID-Affiliated Researcher to Evaluate Brilacidin in Monkeypox
05 Aug 2022 //
ACCESSWIRE
Innovation Pharma Announces New Antiviral Research on Brilacidin
28 Jun 2022 //
ACCESSWIRE
Innovation Pharma Reports Brilacidin Inhibits SARS-CoV-2 Variants
23 Jun 2022 //
ACCESSWIRE
Innovation Pharma Acquires Stake in Squalus Medical
15 Jun 2022 //
ACCESSWIRE
Innovation Pharmaceuticals Provides Brilacidin Program Update
18 Nov 2021 //
BIOSPACE
Database Lock Completed for Innovation`s Phase 2 Trial of Brilacidin
03 Nov 2021 //
YAHOOFINANCE
Innovation Pharmaceuticals` COVID-19 Clinical Trial Topline Results Anticipated
25 Oct 2021 //
YAHOO
Innovation Provides Update on COVID-19 Clinical Trial
23 Sep 2021 //
IPHARMINC
Innovation Pharmaceuticals Provides Update on Brilacidin Antiviral Research
02 Aug 2021 //
GLOBENEWSWIRE
Innovation’s drug shows antiviral activity against Covid-19 in study
23 Jul 2021 //
PHARMACEUTICAL TECHNOLOGY
Innovation’s drug shows antiviral activity against Covid-19 in study
23 Jul 2021 //
PHARMACEUTICAL TECHNOLOGY
Innovation’s drug shows antiviral activity against Covid-19 in study
23 Jul 2021 //
PHARMACEUTICAL TECHNOLOGY
Innovation New In Vitro Data Supporting Broad-Spectrum Antiviral Potential
22 Jul 2021 //
GLOBENEWSWIRE
Innovation New In Vitro Data Supporting Broad-Spectrum Antiviral Potential
22 Jul 2021 //
GLOBENEWSWIRE
Innovation Pharma Announces New Brilacidin Antiviral Research on Non-SARS-CoV-2
18 Jun 2021 //
GLOBENEWSWIRE
Innovation Pharma Completes Enrollment in Phase 2 Clinical Trial for COVID-19
03 Jun 2021 //
GLOBENEWSWIRE
Patient Enrollment Reaches 90 Percent in Innovation Pharmaceuticals Phase 2
27 May 2021 //
GLOBENEWSWIRE
Innovation Pharma Files Form 10-Q; Patient Enrollment in Phase 2 Clinical Trial
13 May 2021 //
GLOBENEWSWIRE
Innovation Pharma Surpasses 50 Percent Enrollment in Phase 2 Clinical Trial
28 Apr 2021 //
GLOBENEWSWIRE
Innovation Broad Spectrum Antiviral Drug Candidate Brilacidin Highlighted
14 Apr 2021 //
GLOBENEWSWIRE
Innovation Pharma Announces Brilacidin Abstract Accepted for Oral Presentation
07 Apr 2021 //
GLOBENEWSWIRE
Innovation Pharma to increase dosing frequency in Covid-19 drug trial
06 Apr 2021 //
CLINICALTRIALSARENA
Innovation Pharma’s COVID-19 Drug Candidate Brilacidin Ranked in Top
10 Mar 2021 //
GLOBENEWSWIRE
Innovation Announces Publication of Peer-Reviewed Scientific Article
02 Mar 2021 //
GLOBENEWSWIRE
Innovation Pharma Provides Study Details for Ongoing Phase 2 Trial of Brilacidin
26 Feb 2021 //
BIOSPACE
Innovation ’ Ph 2 Clinical Trial of Brilacidin for Treating COVID-19 Next Week
29 Jan 2021 //
YAHOO
Innovation Brilacidin for the Treatment of COVID-19 Receives FDA FTD
14 Jan 2021 //
GLOBENEWSWIRE
Innovation Pharmaceuticals Receives Pre-IND Response from FDA on COVID-19 Trial
02 Nov 2020 //
GLOBENEWSWIRE
Innovation and George Mason University Announce Public Release
30 Oct 2020 //
BIOSPACE
Innovation Pharmaceuticals Announces Pre-IND Meeting Request Granted by FDA
03 Oct 2020 //
GLOBENEWSWIRE
Brilacidin for COVID-19 in Combination with Remdesivir Reduces Viral
15 Sep 2020 //
GLOBENEWSWIRE
Innovation Pharmaceuticals Announces Publication of Research on Kevetrin
08 Sep 2020 //
GLOBENEWS WIRE
Innovation’s Brilacidin shows promise in-vitro against Covid-19
25 Aug 2020 //
PHARMACEUTICALTECHNOLOGY
COVID-19 Drug Candidate Brilacidin Achieves a Selectivity Index
24 Aug 2020 //
GLOBENEWSWIRE
Innovation & U.S. Regional Biocontainment Lab Nearing Completion of Brilacidin
04 Aug 2020 //
GLOBENEWSWIRE
Innovation Pharma Brilacidin Inhibits Novel Coronavirus COVID-19 by Almost 90%
20 Jul 2020 //
GLOBENEWSWIRE
In Vitro Testing of Innovation ’ Brilacidin for COVID-19 Shows Consistent
07 Jul 2020 //
PRESS RELEASE
Innovation Collaborating with Regional Biocontainment Lab on Grant Application
11 Jun 2020 //
IPHARMINC
Innovation Pharmaceuticals Receives Data from Public Health Research Institute
26 May 2020 //
IPHARMINC
Innovation Pharma’ Brilacidin Reduces Viral Titer of SARS-CoV-2 (COVID-19)
19 May 2020 //
GLOBENEWSWIRE
Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on SARS-CoV-2
05 May 2020 //
IPHARMINC
Innovation Pharmaceuticals in Discussions to Advance Brilacidin Against COVID-19
06 Apr 2020 //
TYAHOO
Innovation Pharma Completes Interim Safety Data Review—DMC Approves
05 Apr 2020 //
GLOBENEWSWIRE
Innovation Receives Data Supporting Brilacidin’s Direct Inhibition SARS-CoV-2
01 Apr 2020 //
GLOBENEWSWIRE
U.S. Regional Biocontainment Lab to Begin Testing of Brilacidin
10 Mar 2020 //
PRESS RELEASE
Innovation`s Plans for Ph2 Trial of New Treatment for Ulcerative Colitis
05 Mar 2020 //
GLOBENEWSWIRE
Innovation to Ship Brilacidin to US Regional Biocontainment Lab COVID-19
27 Feb 2020 //
BUSINESSINSIDER
Innovation`s SubmitMTA to Study Lead Defensin Mimetic Brilacidin for Coronavirus
24 Feb 2020 //
IPPHARMINC
Innovation Pharma Exploring Lead Defensin Mimetic Drug Candidate Brilacidin
18 Feb 2020 //
GLOBENEWSWIRE
Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis
13 Feb 2020 //
GLOBENEWSWIRE
